Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-07-30 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2018-10-09 | New | $341,710 | $341,710 | Equity Only | 06b | SEC link |
| 2018-07-09 | New | $7,571 | $7,571 | Equity Only | 06b | SEC link |
| 2017-08-31 | New | $133,875 | $133,875 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jennifer Bath | Director, Executive |
| Robert Beecroft | Director, Executive |
| Robert Burke | Director |
| Chris Buyse | Director |
| Guy Champagne | Director |
| Thomas D'orazio | Director, Executive |
| James Kuo | Director |
| Mitch Levine | Director |
| Ilse Roodnik | Executive |
| Greg Smith | Director |
| Barry Springer | Director |
| Kristin Taylor | Executive |
| Natasha Tsai | Executive |
| Dawn Wattie | Executive |
| Dirk Witters | Director |